<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01953068</url>
  </required_header>
  <id_info>
    <org_study_id>R13043</org_study_id>
    <nct_id>NCT01953068</nct_id>
  </id_info>
  <brief_title>Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures</brief_title>
  <official_title>Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Up to 50% of patients undergoing surgical aortic valve operation suffer from some level of
      post-operative cognitive dysfunction (POCD). Frontal lobes of the brain, where executive
      functions are located, are highly susceptible to trauma caused by possible blood malperfusion
      to these areas of the brain during surgery. Conventional and established neuropsychological
      test methods are poor in distinguishing these kinds of trauma, as they are isolated,
      structured tests that do not require multitasking and processing of multiple stimuli at the
      same time.

      The phase 1 goal of this study is to employ an experimental Executive reaction time (RT) test
      to see if this method could improve objective detection of subtle brain dysfunction assumed
      to underlie persistent cognitive, somatic, and affective complaints reported by patients who
      have undergone electic aortic valve replacement (AVR) surgery. Phase 2 of the study will
      concentrate on patients undergoing transcatheter aortic valve implantation (TAVI).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Executive Reaction Time Test response speed</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Executive Reaction Time Test: error% of answers</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Neurobehavioral Manifestations</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Elective aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI)
        patients at Tampere University Hospital Heart Center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing elective aortic valve stenosis surgery (phase 1) or transcatheter aortic
             valve implantation (phase 2)

        Exclusion Criteria:

          -  Previous neurological or psychiatric disorder.

          -  Significant visual problem

          -  Problems with upper arm/hand use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonne Liimatainen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kaisa Hartikainen, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Behavioral Neurology Research Unit, Pirkanmaa Hospital District</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arvi Yli-Hankala, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kati Järvelä, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital Heart Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kati Järvelä, MD, PhD</last_name>
    <phone>+358331164869</phone>
    <email>kati.jarvela@sydankeskus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonne Liimatainen, MD</last_name>
    <phone>+358331169754</phone>
    <email>jonne.liimatainen@pshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere University Hospital Heart Center</name>
      <address>
        <city>Tampere</city>
        <state>Pirkanmaa</state>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jonne Liimatainen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kati Järvelä, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Panu Virkkala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markku Eskola, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marko Virtanen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kaisa Hartikainen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arvi Yli-Hankala, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2013</study_first_submitted>
  <study_first_submitted_qc>September 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2013</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Kati Järvelä</investigator_full_name>
    <investigator_title>Kati järvelä, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>POCD</keyword>
  <keyword>Executive Reaction Time Test</keyword>
  <keyword>Aortic valve surgery</keyword>
  <keyword>Cognitive functions</keyword>
  <keyword>Transcatheter Aortic Valve Implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Neurobehavioral Manifestations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

